Multi-antigen vaccines for the primary and secondary prevention of bladder cancerto POP: 9/15/2017 - 3/14/2019
Ended Awarded Last action
- Contract number
- HHSN26100006
- Awardee
-
University Of Alabama At Birmingham UEI YND4PLMC9AN7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $636,313
Award facts
- Opportunity
-
- N01CN201500036 Solicitation number
- Contract value 100% obligated
- $636,313.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Birmingham, AL 35294, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $636,313 |
About this award
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $636,313.00 firm fixed price delivery order contract to the University of Alabama at Birmingham (UAB) for "MULTI-ANTIGEN VACCINES FOR THE PRIMARY AND SECONDARY PREVENTION OF BLADDER CANCER." The period of performance is from September 15, 2017 to March 14, 2019. This contract is part of the National Cancer Institute's "PRECLINICAL PREVENT CANCER PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS" and does not have a set-aside designation.
As a subcontractor under this delivery order, the University of Washington is contributing research services. UAB has a history of providing research, engineering, and other services to various federal agencies, including NASA, the Department of Defense, and the National Institutes of Health, through prime and sub-contracts and grants.
Quick answers
Who was awarded contract HHSN26100006?
HHSN26100006 was awarded to University Of Alabama At Birmingham by National Cancer Institute (National Institutes of Health) on September 15, 2017.
How much is contract HHSN26100006 worth?
The government has obligated $636,313 on HHSN26100006.
Is contract HHSN26100006 an order under another contract?
Yes. HHSN26100006 is a delivery order under HHSN261201500036I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).
Was contract HHSN26100006 competed?
The extent of competition for HHSN26100006 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award